Search

Much work has focused on the development of indicator sets to monitor changes in the sustainability of transport. Such indicator sets are however, often quite divorced from those used in decision-making and fail to include clear sustainability goals to work towards. This research describes the development of a sustainability appraisal framework in conjunction with a series of key decision-makers in England. A case study of a real set of strategy options tested in a metropolitan area is outlined and the results used to assess the extent to which current strategy development in the United Kingdom produces the information required to both assess and communicate progress towards sustainability. The results suggest that although sustainability exists as a concept, it is poorly defined. This definition deficit has serious implications for the types of strategies tested. First, information on some aspects of sustainability is not produced and so these aspects are marginalized. Secondly, the lack of policy goals and the dominant welfare economics assessment paradigm allow unsustainable strategies to be justified provided they perform better than an unsustainable 'do-minimum'. The paper concludes with some recommendations for the policy and research communities to bridge the current gap in thinking. [ABSTRACT FROM AUTHOR]

The article focuses on the revision of the Accreditation Council for Pharmacy Education (ACPE) Accreditation Standards and Guidelines for the Professional Degree Program in Pharmacy Leading to the Doctor of Pharmacy Degree in the U.S. in 2007. It presents the new standards and guidelines included in the revision, which are said to narrowly define the duration and nature of the introductory pharmacy practice experiences (IPPE). The authors call on their ACPE colleagues to make essential IPPE changes.

To address the shortage of research-trained pharmaceutical scientists (or doctor of pharmacy [Pharm.D.] scientists), a 2-day pharmacy research conference titled "Pharm.D. Pathways to Biomedical Research" was convened on December 13-14, 2006, at the National Institutes of Health (NIH) campus (Bethesda, MD). The workshop included invited speakers and participants from academia, industry, and government. Forty-two pharmacy schools were represented, including deans and clinical pharmaceutical scientists with current NIH funding. In addition, several pharmacy professional organizations were represented--American Association of Colleges of Pharmacy, American College of Clinical Pharmacy, American Society of Health-System Pharmacists, and the Accreditation Council on Pharmaceutical Education. The workshop was divided into three sessions followed by breakout discussion groups: the first session focused on presentations by leading pharmaceutical scientists who described their path to success; the second session examined the NIH grant system, particularly as it relates to training opportunities in biomedical research and funding mechanisms; and the third session addressed biomedical research education and training from the perspective of scientific societies and academia. We summarize the discussions and findings from the workshop and highlight some important considerations for the future of research in the pharmacy community. This report also puts forth recommendations for educating future pharmaceutical scientists. [ABSTRACT FROM AUTHOR]

Presents a study which reported that during embryonic development in Limulus polyphemus, amebocyte production begins at stage 18. Embryo collection and processing for histological analysis; Immunolocalization and microscopy; Blood cell production during embryogenesis.